BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 31190990)

  • 1. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations.
    Enomoto LM; Shen P; Levine EA; Votanopoulos KI
    Cancer Manag Res; 2019; 11():4231-4241. PubMed ID: 31190990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival.
    Sugarbaker PH; Chang D
    Eur J Surg Oncol; 2017 Jul; 43(7):1228-1235. PubMed ID: 28189456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for refractory malignant ascites in patients unsuitable for cytoreductive surgery.
    Valle SJ; Alzahrani NA; Alzahrani SE; Liauw W; Morris DL
    Int J Surg; 2015 Nov; 23(Pt A):176-80. PubMed ID: 26475090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Cabras AD; Bertulli R; Hutanu I; Deraco M
    Eur J Cancer; 2013 Oct; 49(15):3140-8. PubMed ID: 23831335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant peritoneal mesothelioma: a review.
    Kim J; Bhagwandin S; Labow DM
    Ann Transl Med; 2017 Jun; 5(11):236. PubMed ID: 28706904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma and predictors of survival.
    Gilani SNS; Mehta A; Garcia-Fadrique A; Rowaiye B; Jenei V; Dayal S; Chandrakumaran K; Carr N; Mohamed F; Cecil T; Moran B
    Int J Hyperthermia; 2018 Aug; 34(5):578-584. PubMed ID: 29431036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from gastric cancer: a systematic review.
    Chia CS; Seshadri RA; Kepenekian V; Vaudoyer D; Passot G; Glehen O
    Pleura Peritoneum; 2016 Jun; 1(2):67-77. PubMed ID: 30911610
    [No Abstract]   [Full Text] [Related]  

  • 8. Update on the management of malignant peritoneal mesothelioma.
    Sugarbaker PH
    Transl Lung Cancer Res; 2018 Oct; 7(5):599-608. PubMed ID: 30450299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive surgery (SRC) and hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment of peritoneal carcinomatosis: Our initial experience and technical details.
    Topgül K; Çetinkaya MB; Çiğdem Arslan N; Gül MK; Çan M; Gürsel MF; Erdem D; Malazgirt Z
    Ulus Cerrahi Derg; 2015; 31(3):138-47. PubMed ID: 26504417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry.
    Votanopoulos KI; Sugarbaker P; Deraco M; Morris D; Glehen O; Elias D; De Simone M; Robella M; Heyd B; Kusamura S; Baratti D; Chouliaras K; Russell G; Shen P; Levine EA;
    Ann Surg Oncol; 2018 Mar; 25(3):667-673. PubMed ID: 29260418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.
    Vassos N; Förtsch T; Aladashvili A; Hohenberger W; Croner RS
    World J Surg Oncol; 2016 Feb; 14(1):42. PubMed ID: 26912149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat peritoneal carcinomatosis from gastric cancer: a clinical study of 110 patients].
    Ji ZH; Li XB; Liu G; Yu Y; Lin YL; Zhang YB; Li Y
    Zhonghua Yi Xue Za Zhi; 2018 Oct; 98(38):3079-3083. PubMed ID: 30392267
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a patient with peritoneal carcinomatosis from a pancreatic cystadenocarcinoma: A case report.
    Lin SD; Soucisse ML; Lansom J; Morris DL
    Int J Surg Case Rep; 2019; 63():48-52. PubMed ID: 31563663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoreductive surgery and hyperthermic intraperitoneal perfusion with chemotherapy in children with peritoneal tumor spread: A French nationwide study over 14 years.
    Scalabre A; Philippe-Chomette P; Passot G; Orbach D; Elias D; Corradini N; Brugières L; Msika S; Leclair MD; Joseph S; Brigand C; Becmeur F; Soler C; Pezet D; Gagniere J; Glehen O; Sarnacki S
    Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies.
    Passot G; Bakrin N; Isaac S; Decullier E; Gilly FN; Glehen O; Cotte E
    Eur J Surg Oncol; 2014 Aug; 40(8):957-62. PubMed ID: 24209429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center.
    Yu HH; Yonemura Y; Hsieh MC; Mizumoto A; Wakama S; Lu CY
    Cancer Manag Res; 2017; 9():513-523. PubMed ID: 29089784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases.
    Gros L; Szturz P; Diciolla A; Kirchner V; Peters S; Schaefer N; Hubner M; Digklia A
    Front Oncol; 2021; 11():704295. PubMed ID: 34222029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study.
    van der Kaaij RT; Braam HJ; Boot H; Los M; Cats A; Grootscholten C; Schellens JH; Aalbers AG; Huitema AD; Knibbe CA; Boerma D; Wiezer MJ; van Ramshorst B; van Sandick JW
    JMIR Res Protoc; 2017 Jul; 6(7):e136. PubMed ID: 28705789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
    Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.